Clinical Trials Logo

Glaucoma clinical trials

View clinical trials related to Glaucoma.

Filter by:

NCT ID: NCT00345046 Completed - Cataract Clinical Trials

A Comparison of Three Different Formulations of Prednisolone Acetate 1%

Start date: September 2002
Phase: Phase 4
Study type: Interventional

Generic prednisolone acetate 1% is less effective than Pred Forte 1% or Econopred Plus 1%.

NCT ID: NCT00343746 Recruiting - Glaucoma Clinical Trials

Novel Diagnostics With Optical Coherence Tomography: Retinal Imaging

Start date: October 2005
Phase: N/A
Study type: Observational

The purpose of this research is to evaluate optical coherence tomography (OCT) and FDA approved device used to image diseases of the eye. The ultra-high resolution OCT is a non-significant risk device used in this study. Optical Coherence Tomography may be useful for early diagnosis and monitoring of different types of eye diseases.

NCT ID: NCT00343603 Completed - Glaucoma Clinical Trials

Tracking Optical Coherence Tomography

Start date: October 2004
Phase: Phase 2
Study type: Observational

The purpose of this research study is to evaluate an investigational system that may allow doctors to show images of the different parts inside the eye that show greater detail than current equipment can produce.

NCT ID: NCT00342342 Completed - Glaucoma Clinical Trials

Family Studies of Eye Traits

Start date: December 4, 2002
Phase:
Study type: Observational

This study will examine blood specimens from patients with various eye disorders who previously participated in the Beaver Dam Eye Study to try to identify genes responsible for these disorders. The Beaver Dam study was designed to determine the incidence and causes of age-related eye conditions, including cataract (changes in the lens of the eye that can impair vision); retinopathy (diseases of the retina - the thin layer of tissue that lines the back of the eye); age-related maculopathy (degeneration or atrophy of the macula - the center part of the retina responsible for fine vision); and impaired vision. Findings from this study and others have shown that age-related eye disorders often run in families, indicating a genetic component in their development. All participants in the Beaver Dam study who had family members in the study may be included in the current NHGRI study. The Beaver Dam study included residents of the township of Beaver Dam, Wisconsin, who were between 45 and 84 years of age at enrollment. Participants had thorough eye examinations and blood samples drawn at baseline and 5 and 10 years after the baseline evaluation. Fifteen-year follow-ups will start in 2003. This study will analyze data and blood samples previously collected from Beaver Dam study participants to identify genes related to numerous age-related visual traits. No new participants will be recruited.

NCT ID: NCT00338533 Completed - Glaucoma Clinical Trials

Endoscopic Goniotomy for Infantile Glaucoma

Start date: April 1997
Phase: N/A
Study type: Interventional

Glaucoma surgery is performed on children less than 3 years old for infantile glaucoma which untreated can cause blindness. Glaucoma is an uncontrolled high eye pressure in these children often due to incomplete development of the part of the eye which normally allows fluid to drain out of the eye. Two procedures are possible and equal in their success of lowering the eye pressure. However, one (the goniotomy procedure) is preferred since it takes 10 minutes rather than 1 hour (for the trabeculotomy procedure) to perform under general anesthesia. This is important in young children to reduce anesthesia exposure especially if both eyes need surgery. If the glaucoma has caused the cornea or front of the eye to become too cloudy, then the view is too poor to place a lens on the cornea and use a needle to perform the shorter procedure. However, a small endoscope which has been FDA approved for use in the eye will allow direct viewing of the area which needs treatment. A needle attached to this endoscope allows the shorter goniotomy to be performed rather than proceeding to the longer trabeculotomy procedure. The outcome measure of this study is anesthesia time and reduction in intraocular pressure .

NCT ID: NCT00338208 Completed - Glaucoma Clinical Trials

Adult Providing Access to the Visual Environment (PAVE) - Glaucoma Pilot

PAVE
Start date: October 2003
Phase: N/A
Study type: Interventional

We wish to evaluate a potential training program for patients with glaucoma, to become more efficient users of prescribed low vision devices for distance and near vision tasks. We hypothesize that the devices will improve efficiency. Prescribed devices will include a stand magnifier, a handheld magnifier, spectacle magnifiers for near vision, and a handheld monocular (telescope) and a bioptic telescope (spectacle-mounted telescope) for distance vision. The success of being able to use optical devices is dependent upon training. Optical devices are currently accepted and used for patients with visual conditions that decrease their central vision. The bioptic telescope is a pair of glasses with a small telescope mounted within the carrier lens. The glasses look and feel like a normal pair of glasses, but have a black device (telescope) protruding from the top of one lens for better identifying distance objects. The spectacle magnifier is mounted in a pair of glasses also for near vision

NCT ID: NCT00334750 Completed - Ocular Hypertension Clinical Trials

Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada

Start date: November 2007
Phase:
Study type: Observational

This descriptive, non-interventional study will collect information on the presence of risk factors in newly diagnosed ocular hypertension and open-angle glaucoma patients in Canada.

NCT ID: NCT00333463 Completed - Compliance Clinical Trials

Compliance With Once Daily Glaucoma Medication

Start date: June 2006
Phase: N/A
Study type: Observational

A study to examine patient compliance with once daily glaucoma medication

NCT ID: NCT00333125 Completed - Glaucoma Clinical Trials

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Start date: April 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the intraocular pressure (IOP)-lowering efficacy and safety of two combination products in patients with open-angle glaucoma or ocular hypertension.

NCT ID: NCT00330577 Completed - Ocular Hypertension Clinical Trials

24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients

Start date: April 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the short-term mean 24-hour intraocular pressure control, 24-hour blood pressure effect and safety of Latanoprost/Timolol fixed combination given once in the evening with placebo once in the morning versus timolol maleate 0.5% given twice daily in patients with ocular hypertension and primary open-angle glaucoma.